Back to Search Start Over

Inhibition studies on carbonic anhydrase isoforms I, II, IV and IX with N-arylsubstituted secondary sulfonamides featuring a bicyclic tetrahydroindazole scaffold

Authors :
Federico Da Settimo
Claudiu T. Supuran
Ettore Novellino
Sabrina Castellano
Emma Baglini
Andrea Angeli
Silvia Salerno
Rahul Ravichandran
Monica Viviano
Elisabetta Barresi
Anna Maria Marini
Giorgio Amendola
Sabrina Taliani
Sandro Cosconati
Salerno, Silvia
Amendola, Giorgio
Angeli, Andrea
Baglini, Emma
Barresi, Elisabetta
Marini, Anna Maria
Ravichandran, Rahul
Viviano, Monica
Castellano, Sabrina
Novellino, Ettore
Da Settimo, Federico
Supuran, Claudiu T
Cosconati, Sandro
Taliani, Sabrina
Source :
European Journal of Medicinal Chemistry. 220:113490
Publication Year :
2021
Publisher :
Elsevier BV, 2021.

Abstract

Carbonic Anhydrases (CAs) are pharmaceutically relevant targets for the treatment of several disease conditions. The ubiquitous localization of these enzymes and the high homology shared by the different isoforms represent substantial impediments for the discovery of potential drugs devoid of off-target side effects. As a consequence, substantial efforts are still needed to allow for the full realization of the pharmacological potential of CA modulators. In this contribution, starting from our previous studies, we describe the synthesis of a set of new bicyclic tetrahydroindazoles featuring a secondary sulfonamide. Biological evaluation of the inhibitory activity against the hCA I, II, IV, and IX isoforms allowed drawing a structure-activity relationship profile that was rationalized through theoretical studies. This allowed dissecting the new molecules into the single portions influencing the zinc chelation properties and the selectivity profile thereby offering a new platform for the discovery of new isotype selective CA inhibitors. Carbonic Anhydrases (CAs) are pharmaceutically relevant targets for the treatment of several disease conditions. The ubiquitous localization of these enzymes and the high homology shared by the different isoforms represent substantial impediments for the discovery of potential drugs devoid of off-target side effects. As a consequence, substantial efforts are still needed to allow for the full realization of the pharmacological potential of CA modulators. In this contribution, starting from our previous studies, we describe the synthesis of a set of new bicyclic tetrahydroindazoles featuring a secondary sulfonamide. Biological evaluation of the inhibitory activity against the hCA I, II, IV, and IX isoforms allowed drawing a structure-activity relationship profile that was rationalized through theoretical studies. This allowed dissecting the new molecules into the single portions influencing the zinc chelation properties and the selectivity profile thereby offering a new platform for the discovery of new isotype selective CA inhibitors.

Details

ISSN :
02235234
Volume :
220
Database :
OpenAIRE
Journal :
European Journal of Medicinal Chemistry
Accession number :
edsair.doi.dedup.....3d31c8ffe8244601733445de4b8927c7